Come up with a name for your new list and we'll add to it:
EVS Glaucoma Therapeutics raised a round of funding on September 11, 2013. Investors include
CIT GAP Funds.
EVS Glaucoma Therapeutics (EGT) is a Herndon-based spinout of Euclid Vision Systems that will develop a sustained delivery system for glaucoma medication. EGT will develop an implantable, bio-degradab…